RxDoctor Payments Data

Gordon Shields, MD

Otolaryngology · Tuscaloosa, ALNPI 1922059997

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.7% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 24.3% of the total. 2025 is the largest year on record at $1,067, 9.2 times the $116 reported in 2019.

$2,507in general payments, 2019–2025

Across 100 payments — averaging $25.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron Healthcare Solutions, Inc.$609
  • GSK$605
  • Sanofi$501
  • Inspire Medical Systems, Inc.$173
  • Aerin Medical Inc.$128
  • Intersect ENT, Inc.$108
  • plus $384 from 11 others

What the payments were for

  • Food & beverage$2,37595%
  • Education$1325%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,507 in reported general payments places this provider in the 60th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$178,839
Medicare patients
285
Services billed
1,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl152$3,794
Fluticasone Propionate207$3,225
Ipratropium Bromide50$2,064
Ofloxacin48$1,412
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav70$754
Montelukast Sodium52$593
Mometasone Furoate26$448
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen41$341
Omeprazole19$254
Famotidine39$242
Pantoprazole Sodium21$226
Levocetirizine Dihydrochloride41$196
Mupirocin28$165
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim20$71
Prednisone30$66

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Tuscaloosa

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →